From: Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma
Parameters(n=71) | Percentage |
---|---|
Age | mean 61.8 (26 – 95, median 64) |
Tumor diameter (cm) | mean 3.1 (0.5 – 12.3, median 2.5) |
Tumor location | 39 (54.9%)/32 (45.1%) |
right/left | |
Subtype | 23 (32.4%)/32 (45.1%)/16 (22.5%) |
MMBC/PMBC-A / PMBC-B | |
Pathological stage | 23 (32.4%)/40 (56.3%)/8 (11.3%) |
I/II/III | |
pT | 23 (32.4%)/38 (53.5%)/6 (8.5%)/ 4 (5.6%) |
T1/T2/T3/T4 | |
pLymph node status | 8 (11.3%)/63 (88.7%) |
Positive/Negative | |
Lymphovascular invasion | 15 (21.1%)/56 (78.9%) |
Positive/Negative | |
Nuclear grade | 55 (77.5%)/15 (21.1%)/1 (1.4%) |
1/2/3 | |
EIC | 31 (43.7%)/40 (56.3%) |
Positive/Negative | |
Hormone receptor status | 68 (95.8%)/3 (4.2%) |
Positive/Negative | |
HER 2 status | 1 (1.4%)/70 (98.6%) |
Positive/Negative | |
Ki67 | 8 (11.3%)/63 (88.7%) |
Positive/Negative | |
Recurrence | 7 (9.9%)/64 (90.1%) |
Recurrence/no- Recurrence | |
Recurrence cases (n=7) | 6 (85.7%)/0 (0.0%)/1 (14.3%) |
MMBC/PMBC-A/PMBC-B |